Search Results for "1"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for 1. Results 2151 to 2160 of 2733 total matches.

Another Once-Daily Formulation of Tramadol (Ryzolt)

   
The Medical Letter on Drugs and Therapeutics • May 17, 2010  (Issue 1338)
(Ultram, and others) and combined with acetaminophen (Ultracet, and others). Table 1. Tramadol ...
The FDA has approved tramadol hydrochloride extended-release (Ryzolt – Purdue) for treatment of moderate to moderately severe chronic pain in adults. Tramadol is already available in another extended-release formulation (Ultram ER) and in immediate-release tablets alone (Ultram, and others) and combined with acetaminophen (Ultracet, and others).
Med Lett Drugs Ther. 2010 May 17;52(1338):39-40 |  Show IntroductionHide Introduction

Gepotidacin (Blujepa) — A New Antibiotic for Uncomplicated UTI

   
The Medical Letter on Drugs and Therapeutics • Jan 05, 2026  (Issue 1745)
urogenital gonorrhea; its use for this indication will be reviewed in a future issue.1 Table 1 ...
The FDA has approved gepotidacin (Blujepa – GSK), a triazaacenaphthylene bacterial type II topoisomerase inhibitor, for oral treatment of uncomplicated urinary tract infections (uUTI) in female patients ≥12 years old who weigh ≥40 kg. Gepotidacin is the first triazaacenaphthylene antibiotic to be approved in the US.
Med Lett Drugs Ther. 2026 Jan 5;68(1745):1-3   doi:10.58347/tml.2026.1745a |  Show IntroductionHide Introduction

Drugs That May Cause Psychiatric Symptoms

   
The Medical Letter on Drugs and Therapeutics • Dec 15, 2008  (Issue 1301)
, agitation or depression. Table 1. Some Drug Classes Drug Reactions Comments Amphetamine-like drugs ...
Many drugs can cause psychiatric symptoms, but a causal connection is often difficult to establish. Psychiatric symptoms that emerge during drug treatment could also be due to the underlying illness, previously unrecognized psychopathology, or psychosocial factors. The withdrawal of some drugs can cause symptoms such as anxiety, psychosis, delirium, agitation or depression.

Click here to view the free full article.
Med Lett Drugs Ther. 2008 Dec 15;50(1301):100-3 |  Show IntroductionHide Introduction

Insect Repellents

   
The Medical Letter on Drugs and Therapeutics • Jul 07, 2025  (Issue 1732)
, pants, and socks and avoiding outdoor activities during peak mosquito-biting times.1 Some insect ...
The Centers for Disease Control and Prevention (CDC) and the Environmental Protection Agency (EPA) recommend using insect repellents to avoid being bitten by mosquitoes, ticks, and other arthropods that transmit disease-causing pathogens. Repellents applied to exposed skin should be used in conjunction with other preventive measures such as wearing long-sleeved shirts, pants, and socks and avoiding outdoor activities during peak mosquito-biting times. Some insect repellents are listed in Table 1.
Med Lett Drugs Ther. 2025 Jul 7;67(1732):105-9   doi:10.58347/tml.2025.1732a |  Show IntroductionHide Introduction

Anistreplase for Acute Coronary Thrombosis

   
The Medical Letter on Drugs and Therapeutics • Feb 23, 1990  (Issue 812)
-treated patients (AIMS Trial Study Group, Lancet, 1:545, 1988). A randomized trial in 231 patients ...
Anistreplase (Eminase - SmithKline Beecham, Upjohn), a plasminogen activator also known as APSAC, was recently approved by the US Food and Drug Administration (FDA) for intravenous (IV) thrombolytic treatment of coronary thrombosis. Three other thrombolytic agents - intracoronary urokinase (Abbokinase) and intracoronary or intravenous streptokinase (Streptase; Kabikinase) and alteplase (TPA; Activase)- were previously approved for coronary thrombolysis (Medical Letter, 29:107, 1987).
Med Lett Drugs Ther. 1990 Feb 23;32(812):15-6 |  Show IntroductionHide Introduction

Tretinoin for Photodamaged Skin

   
The Medical Letter on Drugs and Therapeutics • Mar 20, 1992  (Issue 866)
sulfate 2%, a skin irritant, increased epidermal thickness as much as 0.1% tretinoin cream (GJ Fisher et ...
Tretinoin (tret' i noyn; all-trans-retinoic acid; Retin-A), a derivative of vitamin A, has been used for years for topical treatment of acne. More recently, it has also been used to improve the appearance of skin damaged by chronic exposure to the sun, although not approved for this indication by the US Food and Drug Administration.
Med Lett Drugs Ther. 1992 Mar 20;34(866):28-9 |  Show IntroductionHide Introduction

Sirolimus (Rapamune) for Transplant Rejection

   
The Medical Letter on Drugs and Therapeutics • Feb 07, 2000  (Issue 1071)
13 years old) should take a loading dose of 3 mg/m 2 and a maintenance dose of 1 mg/m 2 /day ...
Sirolimus, whlch is structurally related to tacrolimus, has been approved by the FDA for prevention of acute renal transplant rejection. The manufacturer recommends that sirolimus be taken with cyclosporine and corticosteroids.
Med Lett Drugs Ther. 2000 Feb 7;42(1071):13-4 |  Show IntroductionHide Introduction

Colesevelam (Welchol) For Hypercholesterolemia

   
The Medical Letter on Drugs and Therapeutics • Oct 30, 2000  (Issue 1091)
of colesevelam is a six-week randomized trial in 149 patients with moderate hypercholesterolemia, comparing 1 ...
Colesevelam hydrochloride (Welchol - Sankyo Pharma), a nonabsorbed hydrophilic polymer that binds bile acids, has been approved by the FDA for reduction of plasma LDL cholesterol in patients with primary hypercholesterolemia.
Med Lett Drugs Ther. 2000 Oct 30;42(1091):102-4 |  Show IntroductionHide Introduction

Agalsidase beta (Fabrazyme) for Fabry Disease

   
The Medical Letter on Drugs and Therapeutics • Sep 15, 2003  (Issue 1165)
-linked recessive disease with an estimated frequency of about 1 in 50,000 male births. The enzyme ...
Agalsidase beta (Fabrazyme Genzyme) has received accelerated approval from the FDA for treatment of patients with Fabry disease, an inherited lysosomal storage disease caused by deficiency of α-galactosidase A. Agalsidase beta is a recombinant form of human α-galactosidase A. This review provides an overview of this rare disease, including its clinical manifestations. The clinical trials conducted with the new drug are also described, as well as its adverse effects, dosage, and cost. Appropriate indications for use of Fabrazyme are summarized.
Med Lett Drugs Ther. 2003 Sep 15;45(1165):74-6 |  Show IntroductionHide Introduction

Prevention and Treatment of Sunburn

   
The Medical Letter on Drugs and Therapeutics • Jun 07, 2004  (Issue 1184)
to 1 mg/cm 2 , which would give a sunscreen with a labeled SPF of 15 a true SPF of 2 to 4 (SR ...
Solar ultraviolet (UV) light capable of injuring the skin is classified by wavelength into UVA I (340-400 nm), UVA II (320-340 nm) and UVB (290-320 nm). UVB is responsible for most of the erythema of sunburn. UVA has been implicated in the development of phototoxicity and photoaging. The FDA permits sunscreen manufacturers to claim broad-spectrum protection if their products block at least part of UVA II in addition to UVB.

Click here to view the free full article.
Med Lett Drugs Ther. 2004 Jun 7;46(1184):45-6 |  Show IntroductionHide Introduction